Enzymatica AB (publ) (STO:ENZY)

Sweden flag Sweden · Delayed Price · Currency is SEK
1.945
+0.030 (1.57%)
At close: Dec 5, 2025
14.41%
Market Cap 464.84M
Revenue (ttm) 52.73M
Net Income (ttm) -54.14M
Shares Out 242.74M
EPS (ttm) -0.22
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 29,390
Average Volume 94,537
Open 1.905
Previous Close 1.915
Day's Range 1.860 - 1.945
52-Week Range 1.340 - 5.450
Beta 0.26
RSI 47.65
Earnings Date Feb 18, 2026

About Enzymatica AB

Enzymatica AB (publ), a life science company, develops and sells medical devices for infection-related diseases. The company’s product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that can cause cold and flu symptoms. It also provides enzyme formulations for skin care. The company was incorporated in 2007 and is headquartered in Lund, Sweden. [Read more]

Sector Healthcare
Founded 2007
Employees 21
Stock Exchange Nasdaq Stockholm
Ticker Symbol ENZY
Full Company Profile

Financial Performance

In 2024, Enzymatica AB's revenue was 45.58 million, a decrease of -10.47% compared to the previous year's 50.90 million. Losses were -53.18 million, 6.94% more than in 2023.

Financial Statements

News

There is no news available yet.